Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.58 |
| ▸ | SLC15A1 | P46059 | 2/20 | 0.56 |
| ▸ | MMP9 | P14780 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.49 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | CDC25B | P30305 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.45 |
| ▸ | ATM | Q13315 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27981610 | 0.90 | ABCB1 (0.53) | ALDH1A1MAPK1L3MBTL1SLC15A1MMP9 | |
| SCHEMBL16379300 | 0.90 | ALDH1A1 (0.54) | ALDH1A1MAPK1L3MBTL1SLC15A1MMP9 | |
| SCHEMBL12282025 | 0.90 | ALDH1A1 (0.54) | ALDH1A1MAPK1L3MBTL1SLC15A1MMP9 | |
| SCHEMBL12369646 | 0.90 | SLC15A1 (0.59) | ALDH1A1MAPK1L3MBTL1SLC15A1MMP9 | |
| SCHEMBL4900863 | 0.90 | SLC15A1 (0.59) | ALDH1A1MAPK1L3MBTL1SLC15A1MMP9 | |
| SCHEMBL4896293 | 0.90 | SLC15A1 (0.59) | ALDH1A1MAPK1L3MBTL1SLC15A1MMP9 | |
| SCHEMBL11785838 | 0.89 | ALDH1A1 (0.50) | ALDH1A1MAPK1L3MBTL1SLC15A1SLC6A2 | |
| SCHEMBL4908110 | 0.88 | ALDH1A1 (0.58) | ALDH1A1MAPK1L3MBTL1SLC15A1MMP9 | |
| SCHEMBL14194794 | 0.88 | SLC15A1 (0.58) | ALDH1A1MAPK1L3MBTL1SLC15A1MMP9 | |
| SCHEMBL18407618 | 0.88 | CYP19A1 (0.47) | ALDH1A1MAPK1L3MBTL1SLC15A1MMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5134230-A | Disaccharide Antitumor Agent Intermediates | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 1992-07-28 | — | — | US | claimed |
| WO-2023220559-A2 | CATALYST-CONTROLLED SITE-SELECTIVE METHYLENE C-H LACTONIZATION OF DICARBOXYLIC ACIDS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2023-11-16 | — | — | WO | disclosed |
| US-9815766-B2 | Process for double carbonylation of allyl ethers to corresponding diesters | EVONIK DEGUSSA GMBH (DE) | 2017-11-14 | — | — | US | disclosed |
| US-20170174609-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | EVONIK DEGUSSA GMBH (DE) | 2017-06-22 | — | — | US | disclosed |
| EP-3181547-A1 | METHOD FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | Evonik Degussa GmbH (DE) | 2017-06-21 | — | — | EP | disclosed |
| US-8476011-B1 | Construction and use of catalogued nucleic acid libraries that contain advantageously adjusted representations of defined components | BP CORPORATION NORTH AMERICA INC. (US) | 2013-07-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170174609-A1 | PROCESS FOR DOUBLE CARBONYLATION OF ALLYL ETHERS TO CORRESPONDING DIESTERS | CBR3, CBR1, EPOR | ALDH1A1 311/4885MAPK1 1540/4885L3MBTL1 3033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.